Many doctors and scientists think they could improve the diagnosis and understanding of autism spectrum disorders if they had reliable means to identify specific abnormalities in the brain. Such “biomarkers” have proven elusive, often because methods that show promise with one group of patients fail when applied to another. In a new study in Nature Communications , however, scientists report a new degree of success. Their proposed biomarker worked with a comparably high degree of accuracy in assessing two diverse sets of adults.
A map of the brain connections that proved useful in distinguishing patients diagnosed with autism from people without an autism diagnosis.
Credit: Nature Communications